SI-BONE Inc diskutieren
SI-BONE Inc
WKN: A2N7LY / Symbol: SIBN / Name: SI-BONE / Aktie / Ausrüstung & Versorgung / Small Cap /
?
6,49 %
SI-BONE, Inc. (NASDAQ: SIBN) had its price target lowered by analysts at Morgan Stanley from $21.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for SIBN provided by MarketBeat
SI-BONE, Inc. (NASDAQ: SIBN) had its price target lowered by analysts at Truist Financial Co. from $18.00 to $16.00. They now have a "buy" rating on the stock.
Ratings data for SIBN provided by MarketBeat
SI-BONE, Inc. (NASDAQ: SIBN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat
SI-BONE, Inc. (NASDAQ: SIBN) had its price target raised by analysts at Truist Financial Co. from $16.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for SIBN provided by MarketBeat
SI-BONE, Inc. (NASDAQ: SIBN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat
SI-BONE, Inc. (NASDAQ: SIBN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat
SI-BONE, Inc. (NASDAQ: SIBN) had its price target raised by analysts at Needham & Company LLC from $20.00 to $24.00. They now have a "buy" rating on the stock.
Ratings data for SIBN provided by MarketBeat
SI-BONE, Inc. (NASDAQ: SIBN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $25.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat
SI-BONE, Inc. (NASDAQ: SIBN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $22.00 price target on the stock, up previously from $18.00.
Ratings data for SIBN provided by MarketBeat
SI-BONE, Inc. (NASDAQ: SIBN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $24.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat
SI-BONE, Inc. (NASDAQ: SIBN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $25.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat
SI-BONE, Inc. (NASDAQ: SIBN) had its price target raised by analysts at Truist Financial Co. from $20.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for SIBN provided by MarketBeat
SiBone (NASDAQ: SIBN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $25.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat
SiBone (NASDAQ:SIBN) was given a new $20.00 price target on by analysts at Truist Financial Corporation. They now have a "buy" rating on the stock.
Ratings data for SIBN provided by MarketBeat
SiBone (NASDAQ:SIBN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley. They now have a $23.00 price target on the stock.
Ratings data for SIBN provided by MarketBeat
SiBone (NASDAQ:SIBN) had its price target raised by analysts at Needham & Company LLC from $24.00 to $27.00. They now have a "buy" rating on the stock.
Ratings data for SIBN provided by MarketBeat
Neueste Beiträge
Barclays_PLC in Celldex Therapeutics diskutieren